INMED PHARMACEUTICAL

IN
Delayed Quote. Delayed  - 09/25 03:59:04 pm
4.77CAD +0.42%
Prev.4.7500
Open4.8000
High4.8000
Low4.7600
Volume1 826
Latest news
2d ago
3d ago
3d ago
4d ago
Chart INMED PHARMACEUTICALS INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance5,987,557,05
Spread/Res.-20%-37%-32%
Spread/Supp.0,42%0,42%45%
Support4,754,753,30
Financials
Sales 2021 - - -
Net income 2021 -15,3 M -11,4 M -11,4 M
Net Debt 2021 - - -
P/E ratio 2021 -2,41x
Yield 2021 -
Capitalization 24,9 M 18,6 M 18,6 M
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 11
Free-Float 98,9%
Company
InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-03 Earnings Release

Income Statement Evolution
Consensus
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 14,85 CAD
Last Close Price 4,77 CAD
Spread / Highest target 211%
Spread / Average Target 211%
Spread / Lowest Target 211%